DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/z6jz5k/branch_retinal) has announced the addition of the “Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2015” report to their offering. The cli…
(MedPage Today) — Novartis exec says pipeline is promising
DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/tp92d7/rhinoconjunctivit) has announced the addition of the “Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2016” report to their offering. The report pr…
SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting infl…
Women aged 40 years or older who used oral contraceptives may have an increased risk of self-reported glaucoma or ocular hypertension, according to a study. Data were pulled from the National Health and Nutrition Examination Survey, which included 3,40…
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report fi…